MoonLake Stock (NASDAQ: MLTX) stock price, news, charts, stock research, profile.
Open | $42.13 |
Close | $43.97 |
Volume / Avg. | 671.96K / 347.03K |
Day Range | 41.12 - 44.58 |
52 Wk Range | 35.11 - 64.98 |
Market Cap | $2.76B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 61 |
Short Interest | 30.3% |
Days to Cover | 25.17 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of MoonLake (NASDAQ:MLTX) through any online brokerage.
Other companies in MoonLake’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Twist Bioscience (NASDAQ:TWST), SpringWorks Therapeutics (NASDAQ:SWTX), TG Therapeutics (NASDAQ:TGTX) and PTC Therapeutics (NASDAQ:PTCT).
There is no analysis for MoonLake.
MoonLake has a consensus price target of $56.53.
The stock price for MoonLake (NASDAQ: MLTX) is $43.97 last updated June 28, 2024 at 4:05 PM EDT.
There are no upcoming dividends for MoonLake.
MoonLake’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for MoonLake.
MoonLake is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.